Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.
Saved in:
| Title: | Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. |
|---|---|
| Authors: | Walz JS; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany., Kowalewski DJ; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany., Backert L; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany., Nelde A; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany., Kohlbacher O; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany.; d Quantitative Biology Center , University of Tübingen , Tübingen , Germany.; e Biomolecular Interactions , Max Planck Institute for Developmental Biology , Tübingen , Germany., Weide B; f Department of Dermatology , University Hospital Tübingen , Tübingen , Germany., Kanz L; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany., Salih HR; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; g Clinical Collaboration Unit Translational Immunology , German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen , Tübingen , Germany., Rammensee HG; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany., Stevanović S; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2018 Aug; Vol. 59 (8), pp. 1949-1958. Date of Electronic Publication: 2018 Jan 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29295645 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Walz+JS%22">Walz JS</searchLink>; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Kowalewski+DJ%22">Kowalewski DJ</searchLink>; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Backert+L%22">Backert L</searchLink>; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Nelde+A%22">Nelde A</searchLink>; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Kohlbacher+O%22">Kohlbacher O</searchLink>; c Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science , University of Tübingen , Tübingen , Germany.; d Quantitative Biology Center , University of Tübingen , Tübingen , Germany.; e Biomolecular Interactions , Max Planck Institute for Developmental Biology , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Weide+B%22">Weide B</searchLink>; f Department of Dermatology , University Hospital Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Kanz+L%22">Kanz L</searchLink>; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Salih+HR%22">Salih HR</searchLink>; a Department of Hematology and Oncology , University of Tübingen , Tübingen , Germany.; g Clinical Collaboration Unit Translational Immunology , German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Rammensee+HG%22">Rammensee HG</searchLink>; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Stevanović+S%22">Stevanović S</searchLink>; b Department of Immunology , Institute for Cell Biology, University of Tübingen , Tübingen , Germany.; h German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen , Tübingen , Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2018 Aug; Vol. 59 (8), pp. 1949-1958. <i>Date of Electronic Publication: </i>2018 Jan 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29295645 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2017.1403022 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1949 Titles: – TitleFull: Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Walz JS – PersonEntity: Name: NameFull: Kowalewski DJ – PersonEntity: Name: NameFull: Backert L – PersonEntity: Name: NameFull: Nelde A – PersonEntity: Name: NameFull: Kohlbacher O – PersonEntity: Name: NameFull: Weide B – PersonEntity: Name: NameFull: Kanz L – PersonEntity: Name: NameFull: Salih HR – PersonEntity: Name: NameFull: Rammensee HG – PersonEntity: Name: NameFull: Stevanović S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2018 Aug Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 59 – Type: issue Value: 8 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |